ASPEN PHARMACARE HOLDINGS LIMITED
Aspen Pharmacare concludes Novartis Agreement
Aspen Pharmacare, Southern Africa's largest generics manufacturer and the
largest JSE-listed pharmaceutical company, has concluded a twelve-year
product marketing agreement with Novartis South Africa (Pty) Ltd.
The agreement, which is effective from April 1, 2002, makes provision for
Aspen Pharmacare to market a basket of Novartis products including Voltaren.
ends
Issued by: Shauneen Beukes, Shauneen Beukes Communications
Tel & Fax: (012) 661-8467
Cell: 082 389 8900
On Behalf Of: Gus Attridge, Aspen Pharmacare Group Chief Financial
Officer
Tel: (031) 268 9508
Fax: (031) 208 0170
Cell: 083 628 8813
Jan van Ruymbeke, Novartis South Africa (Pty) Ltd,
Executive Director
Tel: (011) 929 2542
Fax: (011) 929 2483
Date: 07/03/2002 05:08:10 PM Produced by the JSE SENS Department
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
